On ECHEMI
Home > Drugs > Liaoning PHARMA-UNION Pharmaceutical Co., Ltd.
Liaoning PHARMA-UNION Pharmaceutical Co., Ltd.
  • Founded in:

    2008-05-12
  • Country:

    China China
  • Address:

    122A Xianghuai Road, Benxi Economic Development Zone
  • Tax NO.:

    91210500673786474R
  • Registered Funds:

    110 million yuan
  • Email:

Related Drugs
Sodium Glutamate for Injection
The main ingredient of this product is sodium glutamate
Name Description Content CAS NO. Registered Holders
L-(+)Sodium glutamate

In severe hepatitis or liver dysfunction, the liver's conversion of ammonia to urea is impaired, resulting in increased blood ammonia and encephalopathy symptoms. The intake of glutamate and arginine is beneficial to reduce and eliminate blood ammonia, thereby improving encephalopathy symptoms.

More

In severe hepatitis or liver dysfunction, the liver's conversion of ammonia to urea is impaired, resulting in increased blood ammonia and encephalopathy symptoms. The intake of glutamate and arginine is beneficial to reduce and eliminate blood ammonia, thereby improving encephalopathy symptoms.

142-47-2 4
Para-aminosalicylic acid isoniazid tablets
The main ingredient of this product is isoniazid p-aminosalicylic acid.
Name Description Content CAS NO. Registered Holders
Pasiniazid

This product is a chemical synthesis of isoniazid (INH) and para-aminosalicylic acid (PAS). INH is mainly effective against mycobacteria in the growth and reproduction period, and may inhibit the synthesis of mycolic acid (myolic acid) of sensitive bacteria and cause cell wall rupture. PAS effectively delays and blocks the acetylation process of INH in the body, enhances the bactericidal effect of the drug and delays the development of bacterial resistance. Clinically confirmed, in combination with other anti-tuberculosis drugs, the anti-tuberculosis efficacy of this product is significantly better than INH, and the incidence of adverse reactions is significantly lower than INH. Animal experiments show that for artificially infected mice, the anti-tuberculosis efficacy of this product is about 5 times that of INH.

More

This product is a chemical synthesis of isoniazid (INH) and para-aminosalicylic acid (PAS). INH is mainly effective against mycobacteria in the growth and reproduction period, and may inhibit the synthesis of mycolic acid (myolic acid) of sensitive bacteria and cause cell wall rupture. PAS effectively delays and blocks the acetylation process of INH in the body, enhances the bactericidal effect of the drug and delays the development of bacterial resistance. Clinically confirmed, in combination with other anti-tuberculosis drugs, the anti-tuberculosis efficacy of this product is significantly better than INH, and the incidence of adverse reactions is significantly lower than INH. Animal experiments show that for artificially infected mice, the anti-tuberculosis efficacy of this product is about 5 times that of INH.

2066-89-9 5
Prothionamide
Name Description Content CAS NO. Registered Holders
Protionamide

Extract from the above information

More

Extract from the above information

14222-60-7 4
Sodium p-aminosalicylate
Name Description Content CAS NO. Registered Holders
Sodium 4-aminosalicylate

133-10-8 8
Sodium p-aminosalicylate for injection
This product is a sterile crystalline powder of sodium p-aminosalicylate. Calculated by average unit, the content of sodium p-aminosalicylate (C7H6NNaO3·2H2O should be 95.0%-105.0% of the labeled amount.
Name Description Content CAS NO. Registered Holders
Sodium 4-aminosalicylate

It has an antibacterial effect only on Mycobacterium tuberculosis. It inhibits the growth and reproduction of Mycobacterium tuberculosis by competitively inhibiting the synthesis of folic acid.

More

It has an antibacterial effect only on Mycobacterium tuberculosis. It inhibits the growth and reproduction of Mycobacterium tuberculosis by competitively inhibiting the synthesis of folic acid.

95.0%-105.0%Label quantity 133-10-8 8
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.